Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort.
Stella KilduffJonathan ButlerHiroshi SogawaSonia SolomonPublished in: Pediatric nephrology (Berlin, Germany) (2021)
Kidney transplant is a safe treatment modality for children with ANCA-related kidney failure. ANCA patients have comparable graft survival when compared to the general transplant population with a low risk of recurrence. Thymoglobulin was used in a higher proportion within the ANCA group compared to the non-ANCA group. Tacrolimus, mycophenolate mofetil/mycophenolic acid, and steroids were the predominant maintenance immunosuppression used in both groups. A higher resolution version of the Graphical abstract is available as Supplementary information.